Actively Recruiting
One-shot Ovarian Stimulation Protocol (One-shot)
Led by Fundación Santiago Dexeus Font · Updated on 2025-02-26
20
Participants Needed
3
Research Sites
21 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The current prospective observational pilot study aims to evaluate the endocrine profile of a single-injection protocol (single CFA + daily oral administration of CC).
CONDITIONS
Official Title
One-shot Ovarian Stimulation Protocol (One-shot)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 40 or younger
- Anti-Mullerian Hormone (AMH) between 1.2 and 3.5 ng/ml or Antral Follicle Count (AFC) between 7 and 20
- No family history of hereditary or chromosomal diseases
- Body mass index (BMI) between 18 and 30 kg/m2
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
Dexeus Mujer Sabadell
Sabadell, Barcelona, Spain, 08203
Actively Recruiting
2
Dexeus Mujer Sant Cugat
Sant Cugat del Vallès, Barcelona, Spain, 08195
Actively Recruiting
3
Departamento de Ginecología Obstetricia y Reproducción. Hospital Universitari Dexeus
Barcelona, Spain, 08037
Not Yet Recruiting
Research Team
N
Nikolaos P Polyzos, MD, PhD
CONTACT
I
Ignacio Rodríguez, MSc
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here